{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:25:27Z","timestamp":1748377527047,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We present a case of a rapid clinical recovery in a critically ill kidney transplant recipient with SARS-CoV-2 positivity, Epstein\u2013Barr virus (EBV) reactivation and probable secondary hemophagocytic lymphohistiocytosis (HLH) treated with etoposide-free regimen, based on dexamethasone and a single dose of rituximab. Although rituximab is often a part of EBV-HLH treatment strategy, its use in simultaneous Coronavirus 2019 disease (COVID-19) and solid-organ transplantation has not been reported yet. We review the current evidence for the potential of SARS-CoV-2 to trigger EBV reactivation, leading to a severe clinical illness. Finally, we compare the clinical features of hyper-inflammatory response typical for severe COVID-19 and classical secondary HLH and discuss the benefits of therapeutic B-cell depletion in both conditions.<\/jats:p>","DOI":"10.1007\/s13730-022-00711-4","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T03:26:31Z","timestamp":1655868391000},"page":"27-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis"],"prefix":"10.1007","volume":"12","author":[{"given":"Derek","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Follows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Torpey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-5251","authenticated-orcid":false,"given":"Ondrej","family":"Suchanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"issue":"5","key":"711_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/tid.12586","volume":"18","author":"I Romiopoulos","year":"2016","unstructured":"Romiopoulos I, et al. Fulminant Epstein-Barr virus-associated hemophagocytic syndrome in a renal transplant patient and review of the literature. Transpl Infect Dis. 2016;18(5):795\u2013800.","journal-title":"Transpl Infect Dis"},{"issue":"23","key":"711_CR2","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465\u201377.","journal-title":"Blood"},{"key":"711_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","volume":"2009","author":"AH Filipovich","year":"2009","unstructured":"Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009;2009:127\u201331.","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"1","key":"711_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12879-021-06638-y","volume":"21","author":"Y Xie","year":"2021","unstructured":"Xie Y, et al. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation. BMC Infect Dis. 2021;21(1):955.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"711_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s13054-020-03384-6","volume":"24","author":"GF Lehner","year":"2020","unstructured":"Lehner GF, et al. Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19. Crit Care. 2020;24(1):657.","journal-title":"Crit Care"},{"issue":"1","key":"711_CR6","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","volume":"11","author":"T Chen","year":"2021","unstructured":"Chen T, et al. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11(1):10902.","journal-title":"Sci Rep"},{"issue":"6","key":"711_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pathogens10060763","volume":"10","author":"JE Gold","year":"2021","unstructured":"Gold JE, et al. Investigation of long COVID prevalence and its relationship to Epstein-Barr Virus reactivation. Pathogens. 2021;10(6):763.","journal-title":"Pathogens"},{"key":"711_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3389\/fimmu.2020.01231","volume":"11","author":"JKP Lam","year":"2020","unstructured":"Lam JKP, et al. Co-infection of cytomegalovirus and Epstein-Barr Virus DIminishes the frequency of CD56(dim)NKG2A(+)KIR(-) NK cells and contributes to suboptimal control of EBV in immunosuppressed children with post-transplant lymphoproliferative disorder. Front Immunol. 2020;11:1231.","journal-title":"Front Immunol"},{"issue":"7","key":"711_CR9","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2(7):e437\u201345.","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"711_CR10","doi-asserted-by":"publisher","first-page":"e00074","DOI":"10.1128\/CMR.00074-20","volume":"34","author":"C Quan","year":"2020","unstructured":"Quan C, et al. Immunopathogenesis of coronavirus-induced acute respiratory distress syndrome (ARDS): potential infection-associated hemophagocytic lymphohistiocytosis. Clin Microbiol Rev. 2020;34(1):e00074-e120.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"711_CR11","doi-asserted-by":"publisher","first-page":"e3110","DOI":"10.1093\/cid\/ciaa1463","volume":"73","author":"KEN Clark","year":"2020","unstructured":"Clark KEN, et al. Assessment of the hemophagocytic lymphohistiocytosis HScore in patients with coronavirus disease 2019. Clin Infect Dis. 2020;73(9):e3110\u20132.","journal-title":"Clin Infect Dis"},{"issue":"9927","key":"711_CR12","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503\u201316.","journal-title":"Lancet"},{"issue":"3","key":"711_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/bjh.12386","volume":"162","author":"D Chellapandian","year":"2013","unstructured":"Chellapandian D, et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013;162(3):376\u201382.","journal-title":"Br J Haematol"},{"issue":"9","key":"711_CR14","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1093\/ndt\/gfp282","volume":"24","author":"C Ponticelli","year":"2009","unstructured":"Ponticelli C, Alberighi ODC. Haemophagocytic syndrome\u2014a life-threatening complication of renal transplantation. Nephrol Dial Transplant. 2009;24(9):2623\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"25","key":"711_CR15","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMc2011117","volume":"382","author":"E Akalin","year":"2020","unstructured":"Akalin E, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"711_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ekir.2020.10.023","volume":"6","author":"V Mahalingasivam","year":"2021","unstructured":"Mahalingasivam V, et al. A systematic review of COVID-19 and kidney transplantation. Kidney Int Rep. 2021;6(1):24\u201345.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"711_CR17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1681\/ASN.2020030348","volume":"31","author":"M Willicombe","year":"2020","unstructured":"Willicombe M, Thomas D, McAdoo S. COVID-19 and calcineurin inhibitors: should they get left out in the storm? J Am Soc Nephrol. 2020;31(6):1145\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"711_CR18","doi-asserted-by":"crossref","first-page":"232470962095010","DOI":"10.1177\/2324709620950107","volume":"8","author":"R Amir","year":"2020","unstructured":"Amir R, et al. Epstein-Barr virus versus novel coronavirus-induced hemophagocytic lymphohistocytosis: the uncharted waters. J Investig Med High Impact Case Rep. 2020;8:2324709620950107.","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"6","key":"711_CR19","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1016\/S2665-9913(21)00059-X","volume":"3","author":"J Avouac","year":"2021","unstructured":"Avouac J, et al. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol. 2021;3(6):e419\u201326.","journal-title":"Lancet Rheumatol"},{"issue":"10","key":"711_CR20","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1016\/S2665-9913(20)30270-8","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta P, et al. B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? Lancet Rheumatol. 2020;2(10):e589\u201390.","journal-title":"Lancet Rheumatol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00711-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-022-00711-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-022-00711-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T14:39:18Z","timestamp":1675262358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-022-00711-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s13730-022-00711-4","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and\/or animal participants"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}